Suchergebnisse - "Timson, David J"

PubPharm (11)

1

Therapies for galactosemia : a patent landscape

enthalten in: Pharmaceutical patent analyst | 2020

von Timson, D.

2

Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity

enthalten in: Scientific reports | 2020

von Ferraro, F. | Corvo, I. | Bergalli, L. | +10

3

Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1)

enthalten in: Chembiochem : a European journal of chemical biology | 2019

von Megarity, C. | Abdel-Aal Bettley, H. | Caraher, M. | +8

4

NAD(P)H quinone oxidoreductase (NQO1) : an enzyme which needs just enough mobility, in just the right places

enthalten in: Bioscience reports | 2019

von Pey, A. | Megarity, C. | Timson, D.

5

Dicoumarol : A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism

enthalten in: Current drug targets | 2017

von Timson, D.

6

UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6) : Role in Cancer and Prospects as a Drug Target

enthalten in: Current cancer drug targets | 2017

von Banford, S. | Timson, D.

7

UDP-galactose 4'-epimerase from the liver fluke, Fasciola hepatica : biochemical characterization of the enzyme and identification of inhibitors

enthalten in: Parasitology | 2015

von Zinsser, V. | Lindert, S. | Banford, S. | +3

8

The Saccharomyces cerevisiae quinone oxidoreductase Lot6p : stability, inhibition and cooperativity

enthalten in: FEMS yeast research | 2014

von Megarity, C. | Looi, H. | Timson, D.

9

The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties

enthalten in: FEBS letters | 2014

von Megarity, C. | Gill, J. | Caraher, M. | +3

10

In silico identification and biochemical characterization of novel inhibitors of NQO1

enthalten in: Bioorganic & medicinal chemistry letters | 2006

von Nolan, K. | Timson, D. | Stratford, I. | +1